Research and Markets (http://www.researchandmarkets.com/research/4dxsqs/computed)
has announced the addition of Wintergreen Research, Inc's new report
"Computed Tomography (CT): Market Shares, Strategies, and Forecasts,
Worldwide, 2013 to 2018" to their offering.
WinterGreen Research announces that it has published a new study
Computed Tomography (CT) Market Shares, Strategy, and Forecasts,
Worldwide, 2013 to 2018. The 2013 study has 412 pages, 185 tables and
figures. Worldwide markets are poised to achieve continuing growth as CT
gains significant new imaging clarity.
CT imaging is useful for healthcare therapeutic decision-making.
Infarctions caused by stroke and extensive bleeding are types of
conditions imaged. Subarachnoid hemorrhage and a ruptured aneurysm are
imaged. Seeing the conditions clearly makes a huge difference in
choosing between different treatment options. CT is a primary diagnostic
tool in oncology. It is used to detect cancer, for oncologic treatment
follow-up and in assessing the lung diseases. In emergency care, CT has
become the primary test for trauma, stroke or chest pain.
According to Susan Eustis, lead author of the study, Superior image
quality brings clinical improvement. Physicians are thrilled when they
can see what is going on so much more clearly. Market leaders in the
highe-slice segments have proven superior image quality. They have
pressure to prove they can incorporate effective dose-reduction
techniques while maintaining image quality. High end imaging modalities
require advanced image management and archival systems. The diagnostic
outcome of molecular imaging is made available to clinicians. Healthcare
IT and molecular imaging exploit the advantage of systems. Effective
distribution of images to clinicians is needed. Integration with
electronic medical records is critical.
This growth is driven in part by the growing popularity of independent
diagnostic centers, which are increasing in number due to patient demand
and the relatively low set-up cost compared to a full,
Other drivers of growth include the increasing demands from governments
for high quality healthcare delivery that is supported with CT imaging.
Significant advances in imaging technologies promise to improve wellness
through earlier and more accurate detection of medical conditions.
Aging population and increase in the chronic disease, congestive heart
failure and diabetes in the population are considered as the main
drivers of the imaging market in the developed nations. Obesity and use
of statins are primary drives of chronic diseases. Lack of exercise and
lack of good nutrition are underlying causes of obesity. A rising fiscal
deficit is expected to inhibit the growth of CT in the developed nations.
CT scans help physicians determine whether curative or palliative
treatment is the best course of treatment. CT works for patients for
esophageal cancer. The CT market is shaped by instruments capable of
high scanning speed. High scanning speed reduces examination time and
radiation exposure for patients. CT is useful for managing increasing
rates of cardiovascular disease and cancer. In the face of a population
explosion worldwide demand for healthcare has created a need for
screening and early diagnosis of cardiovascular disease and cancer
- Barco NV
- Esaote Group
- GE Healthcare
- Neurologica Corp.
- Samsung Medison
- STERIS Corporation
- TomTec Imaging Systems GmbH
- Unfors RaySafe
- Market Participants - CT Sytstems
For more information visit http://www.researchandmarkets.com/research/4dxsqs/computed
Source: Wintergreen Research, Inc
[ Back To NFVZone's Homepage ]